News
Altimmune’s Pemvidutide Is Not To Be Dismissed (NASDAQ:ALT)
Altimmune, Inc. (NASDAQ:ALT) is a biopharmaceutical company developing peptide therapeutics like pemvidutide, a dual agonist of GLP-1 and glucagon receptors.…
Credit card spending the leading reason why 78% of Americans have debt regret: survey
A majority of Americans feel financial regret as personal debt soars to new highs, a recent survey said. Roughly 78%…
Turtle Beach: Starting On A Solid Note With PDP (NASDAQ:HEAR)
When Turtle Beach Corporation (NASDAQ:HEAR) announced the acquisition of Performance Designed Products in mid-March, I believed it was game on.…
Diana Shipping Inc. (DSX) Q1 2024 Earnings Call Transcript
Diana Shipping Inc. (NYSE:DSX) Q1 2024 Earnings Conference Call May 28, 2024 9:00 AM ET Company Participants Ed Nebb -…
IQVIA: Potential AI Beneficiary (NYSE:IQV)
IQVIA (NYSE:IQV) provides a broad range of services to biopharma customers, with the majority of the company’s revenue coming from…
Listing a home? Here’s how you can maximize your sale
Today's challenging housing market environment makes finding a buyer difficult and getting the most out of a home sale requires…
Dividends And Earnings Say, The S&P’s Current Price Is About Right
The question I have been asked most in recent months is, "Is the current bull market in tech stocks signaling…
Petco Health and Wellness: I Am Not Convinced A Turnaround Is Around The Corner (WOOF)
Investment summary My recommendation for Petco Health and Wellness (NASDAQ:WOOF) is a sell rating. I am not convinced that the…